Table 1.
Full Cohort (n = 119) |
Unvaccinated (n = 31) |
Vaccinated (n = 86) |
p Value | |
---|---|---|---|---|
Age | ||||
Median, IQR | 47 (38–52) | 38.5 (31–50.5) | 48 (41–52) | 0.002 |
Gender (n, %) | ||||
Male | 76 (63.9) | 18 (58.1) | 58 (67.4) | 0.7 |
Female | 37 (31.1) | 10 (32.3) | 27 (31.4) | |
Unknown | 6 (5.0) | 3 (9.7) | 1 (1.2) | |
Race (n, %) | ||||
White | 102 (85.7) | 24 (77.4) | 78 (90.7) | 0.4 |
Black | 6 (5.0) | 3 (9.7) | 3 (3.5) | |
Other | 3 (2.5) | 1 (3.2) | 2 (2.3) | |
Asian or Pacific Islander | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
American Indian | 1 (0.8) | 0 (0.0) | 1 (1.2) | |
Unknown | 7 (5.9) | 3 (9.7) | 2 (2.3) | |
Previous SARS-CoV-2 infection (n, %) | ||||
Yes | 41 (34.5) | 13 (41.94) | 28 (32.6) | <0.001 |
No | 45 (37.8) | 3 (9.7) | 42 (48.8) | |
I don’t know | 26 (21.9) | 12 (38.7) | 14 (16.3) | |
No response | 7 (5.9) | 3 (9.7) | 2 (2.3) | |
Any Comorbidity | 48 (40.3) | 9 (29.0) | 39 (45.4) | 0.2 |
Common Comorbidities | ||||
Hypertension (high blood pressure) | 20 (16.8) | 2 (6.5) | 18 (21.0) | |
Asthma | 7 (5.9) | 1 (3.2) | 6 (7.0) | |
Other autoimmune diseases | 7 (5.9) | 1 (3.2) | 6 (7.0) | |
Cancer—current or past | 6 (5.04) | 1 (3.2) | 5 (5.8) | |
Inflammatory bowel disease | 5 (4.2) | 1 (3.2) | 4 (4.7) | |
Diabetes (any type) | 3 (2.5) | 1 (3.2) | 2 (2.3) | |
Smoking Status | ||||
Never smoked | 103 (86.55) | 27 (87.1) | 76 (88.37) | 0.001 |
Current or former smoker | 10 (8.4) | 1 (3.23) | 9 (10.47) | |
Missing | 6 (5.04) | 3 (9.68) | 1 (1.16) |